NGF/PI3K signaling-mediated epigenetic regulation of delta opioid receptor gene expression

Biochemical and Biophysical Research Communications

Volumn 368, Issue 3, 2008, Pages 755-760

  Chen, Yulong L ^a,b   Law, Ping Yee ^b   Loh, Horace H ^b  

^a BINGHAMTON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Akt; Chromatin remodeling; Delta opioid receptor; Histone modification; Lysine trimethylation; NF B; NGF; PI3K

Indexed keywords

DELTA OPIATE RECEPTOR; HISTONE H3; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ACETYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EPIGENETICS; GENE CONTROL; GENE LOCUS; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; UNTRANSLATED REGION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; NERVE GROWTH FACTOR; NEURONS; NF-KAPPA B; PC12 CELLS; RATS; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

RATTUS;

EID: 39749165022     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.164     Document Type: Article

References (33)

1. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
2. Bigliardi-Qi M., Gaveriaux-Ruff C., Zhou H., Hell C., Bady P., Rufli T., Kieffer B., and Bigliardi P. Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing. Differentiation 74 (2006) 174-185
3. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am. J. Physiol. Cell Physiol. 282 (2002) C1225-C1234
4. Narita M., Kuzumaki N., Miyatake M., Sato F., Wachi H., Seyama Y., and Suzuki T. Role of delta-opioid receptor function in neurogenesis and neuroprotection. J. Neurochem. 97 (2006) 1494-1505
5. Chang S.F., and Mok M.S. The influence of different sub-type delta opioid receptors in nerve growth factor-induced neuronal differentiation in rat pheochromocytoma PC12 cell. Neurosci. Lett. 314 (2001) 29-32
6. Dermitzaki E., Chatzaki E., Gravanis A., and Margioris A.N. Opioids transiently prevent activation of apoptotic mechanisms following short periods of serum withdrawal. J. Neurochem. 74 (2000) 960-969
7. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 (2001) 1217-1281
8. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73 (1976) 2424-2428
9. Abood M.E., and Tao Q. Characterization of a delta opioid receptor in rat pheochromocytoma cells. J. Pharmacol. Exp. Ther. 274 (1995) 1566-1573
10. Inoue N., and Hatanaka H. Nerve growth factor induces specific enkephalin binding sites in a nerve cell line. J. Biol. Chem. 257 (1982) 9238-9241
11. Chen Y.L., Law P.Y., and Loh H.H. Sustained activation of phosphatidylinositol 3-kinase/Akt/nuclear factor {kappa}B signaling mediates G protein-coupled {delta}-opioid receptor gene expression. J. Biol. Chem. 281 (2006) 3067-3074
12. Zhu Y., Hsu M.S., and Pintar J.E. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J. Neurosci. 18 (1998) 2538-2549
13. Georges F., Normand E., Bloch B., and Le Moine C. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study. Brain Res. Dev. Brain Res. 109 (1998) 187-199
14. Huang E.J., and Reichardt L.F. TRK receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 27 (2003) 27
15. Clayton A.L., Rose S., Barratt M.J., and Mahadevan L.C. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 19 (2000) 3714-3726
16. Cheung P., Tanner K.G., Cheung W.L., Sassone-Corsi P., Denu J.M., and Allis C.D. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell. 5 (2000) 905-915
17. Lo W.S., Trievel R.C., Rojas J.R., Duggan L., Hsu J.Y., Allis C.D., Marmorstein R., and Berger S.L. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol. Cell. 5 (2000) 917-926
18. Lee N.H., Weinstock K.G., Kirkness E.F., Earle-Hughes J.A., Fuldner R.A., Marmaros S., Glodek A., Gocayne J.D., Adams M.D., Kerlavage A.R., et al. Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc. Natl. Acad. Sci. USA 92 (1995) 8303-8307
19. Wong K., Zhang J., Awasthi S., Sharma A., Rogers L., Matlock E.F., Van Lint C., Karpova T., McNally J., and Harrod R. Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREB-binding protein-associated factor and hGCN5 acetyltransferases. J. Biol. Chem. 279 (2004) 55667-55674
20. Middleton G., Wyatt S., Ninkina N., and Davies A.M. Reciprocal developmental changes in the roles of Bcl-w and Bcl-x(L) in regulating sensory neuron survival. Development 128 (2001) 447-457
21. Brunet A., Datta S.R., and Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11 (2001) 297-305
22. Yuan J., and Yankner B.A. Apoptosis in the nervous system. Nature 407 (2000) 802-809
23. Chen Y.L., Law P.Y., and Loh H.H. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells. Cancer Res. 64 (2004) 8723-8730
24. Augustin L.B., Felsheim R.F., Min B.H., Fuchs S.M., Fuchs J.A., and Loh H.H. Genomic structure of the mouse delta opioid receptor gene. Biochem. Biophys. Res. Commun. 207 (1995) 111-119
25. Lachner M., and Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14 (2002) 286-298
26. Bannister A.J., and Kouzarides T. Reversing histone methylation. Nature 436 (2005) 1103-1106
27. Martin C., and Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 6 (2005) 838-849
28. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell. 9 (2002) 625-636
29. Chen Y.L., Law P.Y., and Loh H.H. Action of NF-kappaB on the delta opioid receptor gene promoter. Biochem. Biophys. Res. Commun. 352 (2007) 818-822
30. Vakoc C.R., Mandat S.A., Olenchock B.A., and Blobel G.A. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol. Cell 19 (2005) 381-391
31. Saccani S., and Natoli G. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev. 16 (2002) 2219-2224
32. Wang G., Liu T., Wei L.N., Law P.Y., and Loh H.H. DNA methylation-related chromatin modification in the regulation of mouse delta-opioid receptor gene. Mol. Pharmacol. 67 (2005) 2032-2039
33. Bai S., Ghoshal K., and Jacob S.T. Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells. J. Biol. Chem. 281 (2006) 13604-13611